Health and Fitness FDA Approves Epclusa for Treatment of Chronic Hepatitis C Virus Infection by Press on June 28, 2016 Press Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 First regimen to treat all six major HCV genotypes